The vast majority of the critically essential secrets in biology are hidden from researchers. The human microbiome is now considered a human organ, yet the word “microbiome” was not in the research lexicon as…
Continue Reading
Each person is unique in how they react to prescription and over-the-counter medications. Factors like genetics and other medications you take can affect how you metabolize and respond to certain drugs. Understanding these factors…
Continue Reading
In June, the United States Supreme Court abandoned nearly 50 years of precedent and, for the first time in this nation’s history, eliminated a fundamental right: the right to choose. This decision, Dobbs v….
Continue Reading
The underdiagnosed and poor management of COPD exacerbations represents a missed opportunity to prevent patient deterioration through proactive treatment approaches.
Chronic obstructive pulmonary disorder (COPD) remains a leading cause of poor health and mortality the…
Speculation as to whether or not the U.S. will soon be facing a recession has been a recurring conversation among economists as of late. Although popular belief leads many to assume that the healthcare…
Continue Reading
The home is re-emerging as the preferred place for patient care. Accelerated by the pandemic, a growing number of patients view the home as a more comfortable, safe, and convenient environment in which to…
Continue Reading
McKinsey estimates that digital health solutions could cut global healthcare costs by $3 trillion per year by 2030. But we’ll only hit that number if people actually use the digital health solutions we build…
Continue Reading
Although 2022 has brought on a greater sense of normalcy, the past few years have distracted us from one of the most overlooked epidemics plaguing healthcare: prescription drug abuse.
Before Covid-19 diverted attention away from this problem, President Trump signed on to the SUPPORT for Patients and Communities Act of 2018, instating sweeping legislation for initiatives to address the opioid epidemic. The bill, among other initiatives, requires electronic prescriptions for controlled substances (EPCS) for any covered part D drug. Although the official start of the mandate was delayed two years to January 1, 2023, the importance of this federal intervention cannot be…
The pandemic has forced healthcare organizations to rely heavily on telehealth services. In 2020, virtual visits accounted for more than a quarter of all outpatient visits in the U.S., and they’ve been steadily increasing since then. But there is a flip side to this trend. Recent data shows that telehealth is declining in healthcare, which could create a burden for both healthcare systems and patients. Let’s take a look at why this is happening and what can be done about it.
Reasons behind the decline There are several factors driving the decline in telehealth utilization in healthcare settings. One reason is cost…
The current Adderall shortage is of serious concern to both patients who have attention deficit hyperactivity disorder (ADHD) and clinicians. This shortage cannot be quickly alleviated by a simple increase in the amount of medication manufactured, unless the upper limit to the amount of Adderall’s active ingredient that can be manufactured in a given year is raised by the Drug Enforcement Agency (DEA). The limit has been imposed because the active ingredient can be abused as a recreational drug. It is necessary to control the supply of any medication with abuse liability, but this must be achieved without compromising the legitimate…
Continue Reading
